Genetic Mutation Analysis In A VHL Population
OBJECTIVES:
- Obtain laboratory identification and confirmation of research results for gene
mutations in participants previously enrolled in NCI-99-C-0053 who have von
Hippel-Lindau (VHL) syndrome or who are at risk for VHL syndrome.
- Determine genotype status in these participants.
OUTLINE: Participants submit a blood or buccal sample for genetic mutation analysis.
Participants may receive genetic counseling and/or the results of genetic testing, if
desired.
PROJECTED ACCRUAL: A maximum of 260 participants will be accrued for this study.
Observational
N/A
William M. Linehan, MD
Study Chair
NCI - Urologic Oncology Branch
United States: Federal Government
030148
NCT00075348
December 2003
December 2008
Name | Location |
---|---|
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office | Bethesda, Maryland 20892-1182 |